|
8SGN
Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy651H02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine
提交 2023-04-12
|
构建体不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
其他组合
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 G
1–425(425 aa)
|
未记录
|
EDO 1,2-ETHANEDIOL × 23
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 4
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;291 K;1.72M ammonium sulfate,
0.1M Tris pH 8.0
|
分辨率 2.20 Å
R-free 0.237
|
|
8SIC
Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine
提交 2023-04-14
|
构建体不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 E
1–425(425 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;291 K;18% PEG 8000, 0.22 M sodium acetate, 0.1 M sodium cacodylate pH 6.5
|
分辨率 2.76 Å
R-free 0.295
|
|
8SIC
Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine
提交 2023-04-14
|
构建体不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 G
1–425(425 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 9
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;291 K;18% PEG 8000, 0.22 M sodium acetate, 0.1 M sodium cacodylate pH 6.5
|
分辨率 2.76 Å
R-free 0.295
|
|
8SM0
Crystal structure of human complement receptor 2 (CD21) in complex with Epstein-Barr virus major glycoprotein gp350
提交 2023-04-25
|
构建体不同
聚集状态不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 G
1–425(425 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;291 K;1.60M AMMONIUM SULFATE, 2% PEG 400,
0.5% GLYCEROL, 0.1M SODIUM ACETATE PH5.5
|
分辨率 1.68 Å
R-free 0.241
|
|
8SM1
CRYSTAL STRUCTURE OF HUMAN ANTIBODY 769A9 IN COMPLEX WITH EPSTEIN-BARR VIRUS MAJOR GLYCOPROTEIN GP350
提交 2023-04-25
|
构建体不同
配体/离子不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:trimeric
|
链 G
1–425(425 aa)
|
未记录
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 8
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;291 K;1.60M AMMONIUM SULFATE, 2% PEG 400,
0.5% GLYCEROL, 0.1M SODIUM ACETATE PH5.5
|
分辨率 3.29 Å
R-free 0.298
|
|
9MA7
Cryo-EM structure of EBV gp350 D123 in complex with neutralizing antibody 1A12 and 1H5 and non-neutralizing antibody 2E9
提交 2025-03-14
|
聚集状态不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 7
PDB 声明:heptameric
|
链 A
1–470(470 aa)
|
未记录
|
未记录非水小分子
|
ELECTRON MICROSCOPY
cryo-EM缓冲液
pH 7.8
cryo-EM玻璃化条件
冷冻剂 NITROGEN
|
分辨率 3.14 Å
|